JXSS1900065 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
JXSS1900064 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
JXSS1900063 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
JXSS1900062 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
JYSB1700119 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-25 | view |
JYSB1700034 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSZ1700002 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSB1700033 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSZ1700001 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSB1700118 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-25 | view |
JYSZ1700004 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSB1700121 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-25 | view |
JYSB1700036 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSZ1700003 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSB1700120 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-25 | view |
JYSB1700035 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-25 | view |
JYSB2500007 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB1400077 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2014-04-25 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2014-08-27 | view |
JYSB2101100 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB1500296 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2016-02-22 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2016-05-09 | view |